All articles — 4589 total
Interparfums heads into its May 5 earnings print with a notable divergence: the founder-CEO sold shares just weeks ago, while short sellers have been unwinding positions at a brisk pace. Short interest has dropped…
Integrated BioPharma heads into the week with a share price of $0.265 and an ownership structure so concentrated that conventional short-side pressure is almost irrelevant. The ownership picture is the defining feature…
INTC has delivered one of the most dramatic single-week recoveries in semiconductor history, doubling in two months and surging 45% in five sessions to close at $94.75 — a move that has left short sellers scrambling…
Integra LifeSciences heads into its Q1 2026 earnings call — confirmed for May 5 — with short sellers adding aggressively and the stock at a multi-year low of $10.08. Short interest is the dominant story here, and it is…
IHT — InnSuites Hospitality Trust — heads into the end of April with one clear story: its Chairman and CEO has been a persistent seller, and the stock is down nearly 10% on the week. The CEO selling pattern is hard to…
MTY Food Group heads into its May 20 quarterly report with short sellers gradually retreating and the borrow market running at its loosest levels in months — a quiet but notable shift for a stock that has spent most of…
Insteel Industries heads into the final day of April trying to piece together a recovery after the most damaging earnings print in recent memory — while options traders have turned sharply bullish, a divergence worth…
ISSC enters May with a notable short-interest rebuild — shorts up a third in one week — while options traders have turned noticeably more cautious and the company waits to set a date for its Q1 results. The sharpest…
Insight Enterprises reports Q1 2026 results today — April 30 — and walks in with the stock down 4.5% on the week at $73.59, against a backdrop of genuine disagreement between bears and bulls on the Street. The…
Illinois Tool Works heads into its Q1 2026 results — due today, April 30 — with options traders in an unusually bullish posture, even as the Street holds mixed views and the stock has barely budged this week. Options…
Jack Henry & Associates heads into its May 5 earnings call with a sharp and sustained build in short interest — the most notable shift in its positioning profile in months. Short sellers have been piling in with…
AIM ImmunoTech heads into its May 18 earnings date with short interest surging, borrowing costs punishingly high, and a Phase 3 trial announcement doing little to arrest a brutal month-long slide. Short positioning…
Helmerich & Payne heads into tonight's Q2 2026 earnings release having already delivered its sharpest rally in months — and with short sellers visibly retreating. The stock closed Wednesday at $41.05, up nearly 13% on…
HLTO.Y heads into its Q1 2026 results — due May 8 — with the stock having touched a 52-week high this week and a buyback programme quietly absorbing shares in the open market. The most notable development in recent…
HBP has had a steady week on the TSX, closing at CAD 2.05 on April 29 — up 5.7% on the week and 11.4% over the past month. The interesting tension is not the price move itself, but what's happening in the short book…
HEI.A enters the final stretch before its May 22 earnings release with options traders at their most cautious in more than a year — a notable shift for a name that rarely attracts much defensive hedging. The clearest…
Hecla Mining heads into its May 5 earnings call with the stock down nearly 8% on the week — but with short sellers quietly trimming and the Street just turning more constructive. The most notable development is the…
Heartland Express heads into its Q1 2026 earnings call on May 1 with the sharpest options skew in at least a year, even as shorts quietly unwind and the stock sits near a 12-month high. The options market is by far the…
HealthStream enters its May 4 Q1 earnings call in a curious spot: short interest has climbed over the past week even as the broader positioning picture remains anything but stretched, and insiders sold in late March…
ALNT heads into its May 6 Q1 results with a striking contrast: the stock is up 18% over the past month, yet virtually every named executive sold shares on the same day in early April. The insider picture is the…
